Patent · US Active

Anchorage devices comprising an active pharmaceutical ingredient

US10086115B2 · kind B2 · utility

2Cited by

13References

26Claims

0Family size

Assignee

TYRX, Inc. · US

Inventors

William McJames · Montgomery, US
Frank Do · Jersey City, US
Satish Pulapura · Bound Brook Junction, US
Qing Ge · Solon, US

Key dates

Filing date	Oct 4, 2013
Grant date	Oct 2, 2018
Priority date	—
Expiry date	Oct 4, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61L2300/602
WIPO fieldMedical technology
WIPO sectorInstruments

Abstract

An anchorage device comprising a mesh substrate coupled to an implantable medical device is disclosed, where the mesh substrate has a coating comprising a polymer, and the mesh further comprises at least one active pharmaceutical ingredient. The active pharmaceutical agent is designed to elute from the mesh over time. The mesh substrate can be configured to reduce the mass of the anchorage device such that tissue in-growth and/or scar tissue formation at the treatment site is reduced. In some embodiments, the mesh substrate can be formed with a mesh having a low areal density. In some embodiments, the mesh substrate can include one or more apertures or pores to reduce the mass of the substrate.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.